Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
To get Information about patents for active substance and indications
— Speciality pharmaceuticals, Israel
To identify producers of specific APIs
— Market research, Germany
To find patent expiry information for Australia
— Pharmaceutical consulting, Australia
To understand various drug patents throughout the world
— Business development manager, India
To conduct drug patent landscape analysis
— Pharmaceutical R&D, China
Generated: May 25, 2017
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Salix Pharms | XIFAXAN | rifaximin | TABLET;ORAL | 022554-001 | Mar 24, 2010 | RX | Yes | Yes | 7,935,799 | ► Subscribe | ► Subscribe | ||||||||||||||||||
Salix Pharms | XIFAXAN | rifaximin | TABLET;ORAL | 021361-001 | May 25, 2004 | RX | Yes | Yes | 8,741,904 | ► Subscribe | Y | ► Subscribe | |||||||||||||||||
Salix Pharms | XIFAXAN | rifaximin | TABLET;ORAL | 022554-001 | Mar 24, 2010 | RX | Yes | Yes | 8,946,252 | ► Subscribe | ► Subscribe | ||||||||||||||||||
Salix Pharms | XIFAXAN | rifaximin | TABLET;ORAL | 022554-001 | Mar 24, 2010 | RX | Yes | Yes | 8,158,644 | ► Subscribe | Y | ► Subscribe | |||||||||||||||||
Salix Pharms | XIFAXAN | rifaximin | TABLET;ORAL | 021361-001 | May 25, 2004 | RX | Yes | Yes | 7,045,620 | ► Subscribe | Y | Y | ► Subscribe | ||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
To get upcoming patent expirations for certain drugs
— Journalist, USA
To have rapid access to API suppliers, generic drug manufacturers, and patent information pertaining to any given drug product or drug substance.
— Pharmaceutical consulting, USA
To identify drug patent expiration dates for pharmaceutical companies
— Investment analyst, USA
To find patent expirations in Russia
— Pharmaceutical company, Russia
To get nformation about pending patent expiries in the pharmaceutical market
— Sales, Sweden
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
